EUDA Health Holdings Ltd
Datakwaliteit: 100%
€ 6,72
▼
€ 0,41
(-5,75%)
Marktkapitalisatie: 13,63 M
Prijs
€ 7,21
Marktkapitalisatie
13,63 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—
Quick Summary
Belangrijkste Punten
Negative free cash flow of -2,11 M
P/E of 51,11 — premium valuation
Capital efficient — spends only 2,30% of revenue on capex
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)8,22%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
N/A
ROICN/A
Net Margin5,17%
Op. Margin-41,13%
Veiligheid
Debt / Equity
N/A
Current Ratio0,23
Interest CoverageN/A
Waardering
PE (TTM|NTM)
51,11 | 4,20
Boven sectorgemiddelde (-1,17)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Services sector mediaan (515 peers)
Sectorvergelijking
vs Services sector mediaan (515 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 51,1 | -1,2 |
| P/B | — | 1,4 |
| ROE % | — | -16,0 |
| Net Margin % | 5,2 | -19,4 |
| Rev Growth 5Y % | — | 3,8 |
| D/E | — | 0,4 |
Koersdoel Analisten
1 analist
Buy
Huidig
€ 6,72
Koersdoel
€ 55,00
€ 55,00
€ 55,00
€ 55,00
Vooruitzicht
Forward K/W
4,20
Forward WPA
€ 1,60
Omzet Sch.
27,23 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2026 |
€ 1,60
€ 1,60 – € 1,60
|
27,23 M | 1 |
No quarterly estimates available
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 8,22% | Revenue Growth (3Y) | -36,16% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 5,16 M | Net Income (TTM) | 266.672,0 |
| ROE | N/A | ROA | 12,85% |
| Gross Margin | 22,39% | Operating Margin | -41,13% |
| Net Margin | 5,17% | Free Cash Flow (TTM) | -2,11 M |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0,23 |
| Interest Coverage | N/A | Asset Turnover | 2,49 |
| Working Capital | -4,40 M | Tangible Book Value | -3,97 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 51,11 | Forward P/E | 4,20 |
| P/B Ratio | N/A | P/S Ratio | 2,64 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 0,50 | Fwd Earnings Yield | 23,81% |
| FCF Yield | -15,48% | ||
| Market Cap | 13,63 M | Enterprise Value | 13,63 M |
| Per Share | |||
| EPS (Diluted TTM) | 0,09 | Revenue / Share | 2,73 |
| FCF / Share | -1,12 | OCF / Share | -1,05 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 2,30% | FCF Conversion | -791,38% |
| SBC-Adj. FCF | N/A | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Revenue | 4,01 M | 3,71 M | 9,84 M |
| Net Income | -15,36 M | -10,04 M | -24,88 M |
| EPS (Diluted) | -0,47 | -0,44 | — |
| Gross Profit | 762.155,0 | 842.075,0 | 3,35 M |
| Operating Income | -17,34 M | -3,96 M | -12,06 M |
| EBITDA | — | — | — |
| R&D Expenses | — | — | 17.209,0 |
| SG&A Expenses | — | — | — |
| D&A | 173.217,0 | — | — |
| Interest Expense | — | — | — |
| Income Tax | -4.379,0 | -20.789,0 | 17.422,0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Total Assets | 1,70 M | 1,31 M | 25,63 M |
| Total Liabilities | 4,27 M | 8,79 M | 29,14 M |
| Shareholders' Equity | -2,55 M | -7,50 M | -3,52 M |
| Total Debt | — | — | — |
| Cash & Equivalents | — | 189.005,0 | 143.024,0 |
| Current Assets | 762.876,0 | 723.441,0 | 25,03 M |
| Current Liabilities | 4,14 M | 8,72 M | 29,12 M |
{"event":"ticker_viewed","properties":{"ticker":"EUDA","listing_kind":"stock","pathname":"/stocks/euda","exchange":"NASDAQ","country":"US"}}